Mitochondrial Transfer-Driven Immune Evasion in the Tumor Microenvironment

Area of Science:

• Immunology
• Cancer Biology
• Cellular Metabolism

Background:

• The tumor microenvironment (TME) is critical for antitumor immunity, with metabolic interactions playing a key role.
• Immune evasion in cancer involves mechanisms like inhibitory signals and metabolic competition.
• Intercellular mitochondrial transfer is an emerging mechanism of immune evasion within the TME.

Purpose of the Study:

• To elucidate the role of intercellular mitochondrial transfer as a novel mechanism of immune evasion in cancer.
• To investigate how tumor cells transfer mitochondria to T cells and the consequences for T-cell function.
• To explore the therapeutic potential of targeting mitochondrial transfer in cancer immunotherapy.

Main Methods:

• Analysis of intercellular mitochondrial transfer via tunneling nanotubes and extracellular vesicles.
• Assessment of T-cell mitochondrial fitness and function following transfer.
• Investigation of mitophagy imbalance and its impact on T-cell senescence and memory formation.

Main Results:

• Tumor cells can transfer functional or dysfunctional mitochondria to T cells.
• This transfer leads to mitophagy imbalance and homoplasmic replacement of T-cell mitochondria.
• Impaired T-cell function, senescence, and reduced antitumor activity result from mitochondrial transfer.

Conclusions:

• Intercellular mitochondrial transfer is a significant mechanism of tumor immune evasion.
• This process weakens cancer immunosurveillance by compromising T-cell function.
• Targeting mitochondrial transfer presents novel therapeutic opportunities for cancer immunotherapy.